Effect of insulin lispro on glycaemic control in Chinese diabetic patients receiving twice-daily regimens of insulin.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Chinese Medical Journal

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 15377436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.

  2018cites this paper
• Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

  2016cites this paper
• Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review

  2013cites this paper
• Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes.

  2010cites this paper
• An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK

  2009cites this paper
• Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

  2009cites this paper
• Short‐acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta‐analysis

  2009cites this paper
• A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.

  2007cites this paper
• Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness

  2007cites this paper
• Canadian Agency for Drugs and Technologies in Health Short-acting Insulin Analogues for Diabetes Mellitus

  2007cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper